Growth Metrics

Novartis Ag (NVS) Change in Inventory (2022 - 2026)

Novartis Ag's Change in Inventory history spans 5 years, with the latest figure at -$95.0 million for Q1 2026.

  • On a quarterly basis, Change in Inventory fell 272.73% to -$95.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$134.0 million, a 35.58% increase, with the full-year FY2025 number at $34.0 million, changed N/A from a year prior.
  • Change in Inventory hit -$95.0 million in Q1 2026 for Novartis Ag, down from $34.0 million in the prior quarter.
  • Over the last five years, Change in Inventory for NVS hit a ceiling of $90.0 million in Q3 2024 and a floor of -$514.0 million in Q4 2022.
  • Historically, Change in Inventory has averaged -$154.9 million across 5 years, with a median of -$128.0 million in 2024.
  • Biggest five-year swings in Change in Inventory: skyrocketed 372.73% in 2024 and later crashed 272.73% in 2026.
  • Tracing NVS's Change in Inventory over 5 years: stood at -$514.0 million in 2022, then soared by 93.58% to -$33.0 million in 2023, then tumbled by 581.82% to -$225.0 million in 2024, then skyrocketed by 115.11% to $34.0 million in 2025, then tumbled by 379.41% to -$95.0 million in 2026.
  • Business Quant data shows Change in Inventory for NVS at -$95.0 million in Q1 2026, $34.0 million in Q4 2025, and -$128.0 million in Q3 2025.